Our Services

Medical Devices & IVD
Regulatory Services

End-to-end Saudi FDA compliance, licensing, and Authorized Representative support for medical device manufacturers.

Overview

MCS provides regulatory consulting and local representation services to support medical device and IVD manufacturers entering and operating in the Saudi market. We guide manufacturers through Saudi FDA requirements with clarity, accuracy, and full regulatory compliance.

Our team works closely with both local and overseas manufacturers to streamline approvals, reduce regulatory risk, and ensure smooth market access in Saudi Arabia.

Our Role as Your Regulatory Partner

MCS supports manufacturers by acting as a trusted regulatory partner throughout the product lifecycle — from initial classification to post-market compliance.

We help ensure that medical devices and IVD products meet all applicable Saudi FDA requirements while maintaining regulatory continuity and compliance.

Key Focus Areas

Who We Support

“Medical device compliance requires precision, accountability, and deep regulatory understanding. At MCS, we focus on simplifying complex regulatory pathways and supporting manufacturers with clear guidance at every stage. Our commitment is to help our clients enter and operate in the Saudi market with confidence and compliance.”


— CEO, MCS

Get Started Today

Let’s build something great together.

More services

Additional Regulatory Services

Cosmetics

Regulatory support for cosmetic licensing, approvals, and market entry in Saudi Arabia.

Food

Compliance and regulatory assistance for food products entering the Saudi market.

Drug

Regulatory consultation for pharmaceutical licensing and SFDA requirements.

Distributers Search

We connect you with trusted and qualified distributors across Saudi Arabia.

ISO Consultation

ISO certification and compliance support to improve efficiency and reduce risk.

Proceed Toward Your
Next Achievement

Many manufacturers face delays and risks not due to product quality — but because of regulatory complexity, unclear requirements, and inefficient compliance processes.